1-(4-bromophenyl)-2-hydroxy-2-phenyl-2H,3H,5H,6H,7H,8H,9H-1λ⁵-imidazo[1,2-a]azepin-1-ylium

Dear Customer,

We are working. Read MolPort blog with latest update on Covid-19 effect on compound sourcing, our suppliers, logistics, services & answers on FAQ.

MolPort Team


Compound number:
MolPort-002-540-544
IUPAC:
1-(4-bromophenyl)-2-hydroxy-2-phenyl-2H,3H,5H,6H,7H,8H,9H-1λ⁵-imidazo[1,2-a]azepin-1-ylium
IUPAC traditional:
1-(4-bromophenyl)-2-hydroxy-2-phenyl-3H,5H,6H,7H,8H,9H-1λ⁵-imidazo[1,2-a]azepin-1-ylium
SMILES:
OC1(CN2CCCCCC2=[N+]1c1ccc(Br)cc1)c1ccccc1 |c:10|
InChI key:
OUAGPVMVUQOSDC-UHFFFAOYSA-N
Molecular formula:
C20H22BrN2O
Molecular weight: 386.312
Solubility: not available

Marketplace Offers

More Information

Compound Identifiers
Compound number: MolPort-002-540-544

Names, Synonyms and 3rd Party Identifiers
Name: ZINC000013512577
ZINC000013512580
1-(4-bromophenyl)-2-hydroxy-2-phenyl-2,5,6,7,8,9-hexahydro-3H-imidazo[1,2-a]azepin-1-ium
1-(4-bromophenyl)-2-hydroxy-2-phenyl-2,5,6,7,8,9-hexahydro-3H-imidazo[1,2-a]azepin-1-ium bromide
1-(4-bromophenyl)-2-hydroxy-2-phenyl-2H,3H,5H,6H,7H,8H,9H-1?????-imidazo[1,2-a]azepin-1-ylium

InChI
InChI: 1S/C20H22BrN2O/c21-17-10-12-18(13-11-17)23-19-9-5-2-6-14-22(19)15-20(23,24)16-7-3-1-4-8-16/h1,3-4,7-8,10-13,24H,2,5-6,9,14-15H2/q+1
InChI key: OUAGPVMVUQOSDC-UHFFFAOYSA-N

Calculated Properties
Molecular formula: C20H22BrN2O
Molecular weight: 386.312

Other

Sales contact

+1 215 717 7447

+371 67790398

sales@molport.com


Our customer services department will be happy to help you Monday to Friday 7 a.m. to 9 p.m. GMT (2 a.m. - 4 p.m. EST).


2020 MolPort, v3.77, release date 08-07-2020 16:00 (+0200). All rights reserved.
This website or its third-party tools use cookies, which are necessary to its functioning and require to achieve the purposes illustrated in the Cookie Policy. If you want to know more or withdraw your consent to all or some of the cookies, please refer to the Cookie Policy. By clicking on Agree and closing this banner, scrolling this page, clicking a link or continuing to browse otherwise, you agree to the use of cookies.